Header cover image

Norwegian (OSEAX) Pharma Industry Analysis

UpdatedMar 25, 2026
DataAggregated Company Financials
Companies5
  • 7D-2.6%
  • 3M-4.0%
  • 1Y-0.5%
  • YTD-7.7%

Over the last 7 days, the Pharma industry has dropped 5.0%, driven by a pullback from Photocure of 3.5%. As for the longer term, the industry's performance has been flat for the past year. Looking forward, earnings are forecast to grow by 55% annually.

Industry Valuation and Performance

Has the Norwegian Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Wed, 25 Mar 2026NOK 3.5bNOK 1.6b-NOK 60,027,434.0012.8x-58.2x2.2x
Fri, 20 Feb 2026NOK 3.3bNOK 1.6b-NOK 60,027,434.0012.3x-55.8x2.1x
Sun, 18 Jan 2026NOK 3.9bNOK 1.6b-NOK 67,438,434.00497.7x-57.6x2.5x
Tue, 16 Dec 2025NOK 3.6bNOK 1.6b-NOK 67,438,434.00412.1x-53.3x2.3x
Thu, 13 Nov 2025NOK 3.3bNOK 1.6b-NOK 79,791,434.00374.5x-40.7x2.1x
Sat, 11 Oct 2025NOK 3.3bNOK 1.5b-NOK 83,687,434.0013.1x-39.8x2.2x
Mon, 08 Sep 2025NOK 3.5bNOK 1.5b-NOK 87,981,434.0013.6x-39.4x2.3x
Wed, 06 Aug 2025NOK 3.6bNOK 1.5b-NOK 99,333,434.0014.1x-36x2.3x
Fri, 04 Jul 2025NOK 3.4bNOK 1.5b-NOK 91,864,434.00362.9x-37.3x2.2x
Sun, 01 Jun 2025NOK 3.3bNOK 1.5b-NOK 122,678,000.00319.9x-26.6x2.1x
Tue, 29 Apr 2025NOK 3.5bNOK 1.5b-NOK 115,916,000.00157.4x-29.9x2.3x
Thu, 27 Mar 2025NOK 3.3bNOK 1.5b-NOK 131,427,000.00159.9x-25x2.2x
Sat, 22 Feb 2025NOK 3.1bNOK 1.5bNOK 5.5m97.5x560.9x2.1x
Mon, 20 Jan 2025NOK 2.9bNOK 1.5bNOK 22.4m23x131x2x
Wed, 18 Dec 2024NOK 3.1bNOK 1.5bNOK 22.4m23.8x138.1x2.1x
Fri, 15 Nov 2024NOK 2.9bNOK 1.5bNOK 33.3m21.2x88.5x2x
Sun, 13 Oct 2024NOK 3.2bNOK 1.5bNOK 45.2m22.3x70.4x2.1x
Tue, 10 Sep 2024NOK 2.9bNOK 1.5bNOK 105.8m19.8x27.9x2x
Thu, 08 Aug 2024NOK 2.9bNOK 1.5bNOK 49.7m150.5x57.7x2x
Sat, 06 Jul 2024NOK 3.1bNOK 1.5bNOK 49.7m170.5x62.7x2.1x
Mon, 03 Jun 2024NOK 3.4bNOK 1.5bNOK 7.6m193x447.6x2.3x
Wed, 01 May 2024NOK 3.2bNOK 1.5bNOK 18.3m148.1x175.3x2.2x
Fri, 29 Mar 2024NOK 3.1bNOK 1.5bNOK 7.6m162.7x406.3x2.1x
Sun, 25 Feb 2024NOK 3.1bNOK 1.5bNOK 33.1m167x94.4x2.1x
Tue, 23 Jan 2024NOK 3.6bNOK 1.4bNOK 18.6m25.8x195.4x2.6x
Thu, 21 Dec 2023NOK 3.5bNOK 1.4bNOK 18.6m25x188.1x2.5x
Sat, 18 Nov 2023NOK 3.1bNOK 1.4bNOK 18.6m24.1x167.8x2.2x
Mon, 16 Oct 2023NOK 3.5bNOK 1.3b-NOK 38,433,125.0053.8x-90x2.6x
Wed, 13 Sep 2023NOK 2.9bNOK 1.3b-NOK 53,836,125.0050.8x-53.9x2.2x
Fri, 11 Aug 2023NOK 2.9bNOK 1.3b-NOK 37,590,125.0076.4x-77.1x2.2x
Sun, 09 Jul 2023NOK 3.0bNOK 1.2b-NOK 60,357,125.0075.7x-50.2x2.4x
Tue, 06 Jun 2023NOK 3.2bNOK 1.2b-NOK 104,503,000.0082x-30.7x2.6x
Thu, 04 May 2023NOK 3.1bNOK 1.2b-NOK 128,642,000.0075.2x-24x2.7x
Sat, 01 Apr 2023NOK 3.2bNOK 1.1b-NOK 140,813,000.0023.5x-22.8x3x
Price to Earnings Ratio

-22.8x


Total Market Cap: NOK 3.2bTotal Earnings: -NOK 140,813,000.00Total Revenue: NOK 1.1bTotal Market Cap vs Earnings and Revenue0%0%0%
Norwegian Pharma Industry Price to Earnings3Y Average 38.6x202420252026
Current Industry PE
  • Investors are relatively neutral on the Norwegian Pharmaceuticals industry at the moment, indicating that they anticipate long term growth rates to remain steady.
  • The industry is trading close to its 3-year average PS ratio of 2.3x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have improved over the last three years.
  • Revenues for these companies have grown 13% per year.
  • This means that more sales are being generated by these companies overall, and subsequently losses are decreasing too.

Industry Trends

Which industries have driven the changes within the Norwegian Healthcare industry?

NO Market-0.33%
Healthcare-1.89%
Pharma-2.62%
Pharma-2.62%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
SOFTX SoftOx SolutionsNOK 0.0751.6%
+NOK 2.9m
58.2%PS13.4x
ONCIN OncoinventNOK 44.801.1%
+NOK 2.2m
n/aPS10x

Latest News